Eisler Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Eisler Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$2.81M	Buy	28,100 +24,700	+726%	+$2.22M	0.01%	443
2025 Q2	$282K	Sell	3,400 -7,400	-69%	-$590K	﹤0.01%	749
2025 Q1	$876K	Sell	10,800 -16,300	-60%	-$1.46M	0.01%	720
2024 Q4	$2.48M	Buy	+27,100	New	+$2.63M	0.01%	552

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Eisler Capital Management's XBI Position: Q3 2025 in Review

Eisler Capital Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 59% in Q3 2025, selling an estimated $1.1M and leaving 8,443 shares worth $843K. The position accounts for ﹤0.01% of the portfolio, ranked #583.

Eisler Capital Management first reported a position in XBI in Q4 2024 and has held it in 4 quarters since. The position peaked at $2.44M in Q4 2024. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

Eisler Capital Management held 8,443 shares of State Street SPDR S&P Biotech ETF worth $843K as of Q3 2025.
Eisler Capital Management sold 12,266 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $1.1M.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Eisler Capital Management's portfolio in Q3 2025, its #583 holding.
Eisler Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and has held it in 4 quarters since.
Eisler Capital Management's State Street SPDR S&P Biotech ETF position peaked at $2.44M in Q4 2024.
656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on Eisler Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.